Shanghai Bioheart Biological Technology Co Ltd

Shanghai Bioheart Biological Technology Co Ltd operates as an interventional cardiovascular device company in the Peoples Republic of China The company focuses on the provision of bioresorbable scaffolds BRS and renal denervation RDN therapies for the treatment of coronary artery diseases and uncontrolled and resistant hypertension It is developing Bioheart a BRS system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease Iberis 2nd a multielectrode RDN product candidate and drug coated balloon a sirolimus drugeluting balloon catheter designed for instent restenosis The company has collaboration agreements with Terumo China Investment Co Ltd to conduct clinical trials for Iberis 2nd Shanghai Bioheart Biological Technology Co Ltd was founded in 2014 and is headquartered in Shanghai the Peoples Republic of China